In MDS, concurrent spliceosome gene mutations, such as SRSF2 and SF3B1, are associated with HR-MDS, higher marrow blast percentage, and dysregulations of RNA splicing and DNA methylation pathways [13]. Here, SF3B1 is linked to myelodysplastic syndrome.